Highlights
1 patentProfile claimed by owner
About
Improving Enzymes for Glucose Monitoring
SmartZyme Biopharma develops novel enzymesfor a variety of medical applications. Based on its proprietary proteinengineering platform, the Provolution, the companydesigns enzymes for improved clinical performanceby engineering them for efficacy and safety. Initially, SmartZyme is focusing on products for diabetes patients, including glucose monitoring test strips and patches. TheProvolution system combines advanced computationalmethods with a random mutagenesis approach, processingmultiple protein characteristics that are required for optimalperformance.
Identity
| Name | SmartZyme Biopharma |
|---|---|
| Slug | smartzyme |
| Type / kind | startup |
| Crunchbase ID | smartzyme |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN79hbEIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Golda Me'ir St 5, Ness Ziyyona, Israel |
Web & social
| Website | http://smzyme.com/ |
|---|---|
| https://www.linkedin.com/company/4857689 | |
| Twitter / X | https://twitter.com/SmartZyme |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business models
B2B
Tags
wearablediabetesbioinformaticschronic-patientswearable
Funding
| Total raised | $10.5M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}